Sibutramine

CHEMBL1419 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
279.8 g/mol
LogP
5.4
Phase
4

Sibutramine is a centrally acting serotonin-norepinephrine reuptake inhibitor originally developed as an antidepressant and later used as an anti-obesity agent for weight management. By inhibiting reuptake of serotonin, norepinephrine, and to a lesser extent dopamine, it promotes satiety and reduces food intake while modestly increasing energy expenditure. It was withdrawn from markets in many countries due to increased risk of major adverse cardiovascular events in high-risk patients.

Peso molecular

279,8000 g/mol

LogP

5,40

TPSA

3,20 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1

InChI

InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3

Molecular Formula

C17H26ClN

HBD / HBA

- / 1

Enlaces Rotables

5

Átomos Pesados

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Sibutramine is a centrally acting serotonin-norepinephrine reuptake inhibitor originally developed as an antidepressant and later used as an anti-obesity agent for weight management. By inhibiting reuptake of serotonin, norepinephrine, and to a lesser extent dopamine, it promotes satiety and reduces food intake while modestly increasing energy expenditure. It was withdrawn from markets in many countries due to increased risk of major adverse cardiovascular events in high-risk patients.

Yes, Sibutramine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1419. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5210. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.